Skip to main content

Table 2 ST-segment analysis

From: No effects on myocardial ischaemia in patients with stable ischaemic heart disease after treatment with ramipril for 6 months

  

Ramipril 5 mg

Ramipril 1.25 mg

Placebo

Variable

Visit

n

Mean

SD

n

Mean

SD

n

Mean

SD

STD duration (min)

Baseline

133

361

443

133

393

468

123

426

467

 

1 month

123

319

463

120

326

473

113

406

480

 

Study end

117

332

480

116

367

493

113

318

418

Ischaemic burden

Baseline

133

1428

3248

133

1571

3213

123

1387

2299

 

1 month

123

1309

2950

120

1302

2855

113

1366

2505

 

Study end

117

1276

2612

116

1467

3394

113

1101

2527

Maximum STD (mV)

Baseline

133

0.23

0.09

133

0.24

0.10

123

0.26

0.11

 

1 month

123

0.18

0.12

121

0.20

0.13

113

0.22

0.12

 

Study end

118

0.22

0.15

116

0.22

0.13

113

0.23

0.14

  1. There were no significant differences in the changes from baseline to study end between the ramipril groups and placebo. STD is defined as ST-segment depression of ≥ 0.1 mV. STD duration and ischaemic burden are given per 24 h. SD, standard deviation.
Back to article page

Trials

ISSN: 1745-6215